Literature DB >> 8911005

Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time.

W Künzel1, H Glathe, H Engelmann, C Van Hoecke.   

Abstract

We studied differences in immune responses after first time immunization with a trivalent inactivated split influenza vaccine, or after vaccination in the preceding year, in 42 healthy volunteers (40 +/- 13 years). Sequential serum samples were collected over 40 weeks. Previously vaccinated volunteers exhibited 40-92% protective antibody levels in their prevaccination sera. Subjects vaccinated for the first time had higher response rates and meanfold antibody increases than those vaccinated previously. Both groups had protective antibody titres 59% 7 days after vaccination and 70% of vaccinees maintained protective antibody titres after 280 days. The results corroborate earlier findings on the rapid immune response and may have a bearing on future vaccination policy.

Mesh:

Substances:

Year:  1996        PMID: 8911005     DOI: 10.1016/0264-410x(96)00061-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  31 in total

1.  Comparison of complement fixation and hemagglutination inhibition assays for detecting antibody responses following influenza virus vaccination.

Authors:  Harry E Prince; Amy L Leber
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

Review 2.  Factors affecting immune responses to the influenza vaccine.

Authors:  Maria R Castrucci
Journal:  Hum Vaccin Immunother       Date:  2017-07-21       Impact factor: 3.452

3.  Timeliness of pediatric influenza vaccination compared with seasonal influenza activity in an urban community, 2004-2008.

Authors:  Annika M Hofstetter; Karthik Natarajan; Daniel Rabinowitz; Raquel Andres Martinez; David Vawdrey; Stephen Arpadi; Melissa S Stockwell
Journal:  Am J Public Health       Date:  2013-05-16       Impact factor: 9.308

4.  Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals.

Authors:  J J Goronzy; J W Fulbright; C S Crowson; G A Poland; W M O'Fallon; C M Weyand
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 5.  Evaluating the case for trivalent or quadrivalent influenza vaccines.

Authors:  David Baxter
Journal:  Hum Vaccin Immunother       Date:  2016-07-19       Impact factor: 3.452

Review 6.  Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly.

Authors:  Monique P Curran; Isabel Leroux-Roels
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

7.  Effects of mass media coverage on timing and annual receipt of influenza vaccination among Medicare elderly.

Authors:  Byung-Kwang Yoo; Margaret L Holland; Jay Bhattacharya; Charles E Phelps; Peter G Szilagyi
Journal:  Health Serv Res       Date:  2010-10       Impact factor: 3.402

Review 8.  Humoral immune response to influenza vaccination in patients from high risk groups.

Authors:  L B Brydak; M Machala
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

9.  Seasonal maintenance of influenza vaccine-induced antibody response in kidney transplant recipients.

Authors:  Kelly A Birdwell; Mine R Ikizler; Li Wang; Daniel W Byrne; Edith C Sannella; Peter F Wright; T Alp Ikizler
Journal:  Am J Nephrol       Date:  2012-08-17       Impact factor: 3.754

10.  Immunogenicity and safety of three 2010-2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: a double-blind and randomized trial.

Authors:  Feng-Ji Luo; Li-Qing Yang; Xing Ai; Yun-Hua Bai; Jiang Wu; Shu-Ming Li; Zheng Zhang; Min Lu; Li Li; Zhao-Yun Wang; Nian-Min Shi
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.